Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ptc Therapeutics (PTCT) Leases (2019 - 2025)

Ptc Therapeutics (PTCT) has 7 years of Leases data on record, last reported at $80.1 million in Q4 2025.

  • For Q4 2025, Leases rose 41.22% year-over-year to $80.1 million; the TTM value through Dec 2025 reached $80.1 million, up 41.22%, while the annual FY2025 figure was $80.1 million, 41.22% up from the prior year.
  • Leases reached $80.1 million in Q4 2025 per PTCT's latest filing, down from $80.7 million in the prior quarter.
  • Across five years, Leases topped out at $141.6 million in Q2 2022 and bottomed at $56.2 million in Q2 2025.
  • Average Leases over 5 years is $83.3 million, with a median of $80.7 million recorded in 2021.
  • Peak YoY movement for Leases: surged 173.77% in 2021, then crashed 40.91% in 2024.
  • A 5-year view of Leases shows it stood at $77.4 million in 2021, then skyrocketed by 32.3% to $102.4 million in 2022, then dropped by 10.28% to $91.9 million in 2023, then crashed by 38.32% to $56.7 million in 2024, then soared by 41.22% to $80.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $80.1 million in Q4 2025, $80.7 million in Q3 2025, and $56.2 million in Q2 2025.